Nanobiotix share price logo

Nanobiotix

NASDAQ: NBTX

Small Cap

$34.83

-0.50

(-1.42%)

Live

as on

Nanobiotix Stock Performance

as on June 13, 2026 at 6:35 am IST

  • Day's Low

    Day's High

    $33.51
    $35.99
    downward going graph

    3.79%

    Downside

    3.33%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.18
    $57.14
    downward going graph

    88.00%

    Downside

    64.05%

    Upside

    downward going graph

Nanobiotix share price movements today

Previous Close
$35.33
Open
$33.51
Volume
209.5K
Day's Low - High
$33.51 - $35.99
52 Week Low - High
$4.18 - $57.14

Nanobiotix Historical Returns

1 Month Return
-26.76 %
3 Month Return
+ 12.09 %
1 Year Return
+ 513.37 %
3 Year Return
+ 585.62 %
5 Year Return
0 %

Nanobiotix Stock Fundamentals & Key Indicators

Check Nanobiotix market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7B

EPS (TTM)

0.0425

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-10.5M

Revenue (TTM)

32.6M

Profit Margin

-73.52%

Return On Equity TTM

-198.69%

Nanobiotix vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nanobiotix with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Nanobiotix image
Nanobiotix
BUY$1.7BNANA-73.52%NA
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.7B75.37%74.6112.55%NA
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$113.1B130.57%26.4635.51%NA
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$64.6B16.35%15.0429.65%0.59%

Stock Returns calculator for Nanobiotix Stock including INR - Dollar returns

The Nanobiotix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Nanobiotix investment value today

Current value as on today

₹6,71,950

Returns

₹5,71,950

(+571.95%)

Returns from Nanobiotix Stock

₹5,04,687 (+504.69%)

Dollar Impact

₹67,262 (+67.26%)

Analyst Recommendation on Nanobiotix Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Nanobiotix. Average target price of $42.59

Nanobiotix Share Price Target

Get share price movements and forecasts by analysts on Nanobiotix.

What analysts predicted

18.22%UPSIDE

Target Price

$42.59

Current Price

$34.83

Analyzed by

10 Analysts

Target

$42.59

Nanobiotix target price $42.59, a slight upside of 18.22% compared to current price of $34.83. According to 10 analysts rating.

Indian Investors' Interest in Nanobiotix Stock

Search interest for Nanobiotix Stock has increased by 257% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:257% versus previous 30 day period

Nanobiotix Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Jun 2024
Mar 2025
Jun 2025
Dec 2025
Total Revenue
1
3
3
16
32
9
-16
26
3
Gross Profit
1
3
3
16
32
9
-16
26
3
Operating Income
-10
-20
-25
0
-1
-23
-44
0
-11
EBITDA
-10
-20
-24
0
0
-22
-44
1
-13
Interest Expense
-
3
3
-
3
-
8
3
6
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-15
-30
-28
-5
-11
-21
-46
-5
-18
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-15
-32
-30
-5
-11
-21
-46
-5
-18
Net Profit Margin
-890.17%
-890.17%
-853.29%
-35.25%
-35.25%
-235.46%
280.72%
-20.21%
-618.24%

Nanobiotix Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
4
3
2
2
2
5
39
-7
29
Gross Profit
5
4
3
2
2
2
5
39
-7
29
Operating Income
-21
-25
-30
-46
-36
-52
-46
-26
-68
-10
EBITDA
-21
-24
-29
-45
-34
-45
-44
-23
-67
-12
Interest Expense
0
0
0
4
0
0
5
7
8
10
Depreciation
-
0
0
1
1
1
1
1
1
1
Income Before Tax
-21
-26
-30
-50
-33
-46
-57
-39
-68
-23
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-23
-30
-34
-56
-40
-53
-60
-43
-71
-23
Net Profit Margin
-403.58%
-702.39%
-872.23%
-2003.74%
-1444.73%
-1775.71%
-1194.33%
-109.64%
947.59%
-80.83%

Nanobiotix Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Mar 2025
Jun 2025
Dec 2025
Net Income
-30
-28
-5
-5
-11
-21
-46
-5
-18
Operating Cash Flow
-19
-17
2
-
4
-5
-13
-17
-16
Investing Cash Flow
0
0
-
-
0
0
0
0
0
Financing Cash Flow
-2
-2
24
-
48
-2
-2
-2
40
Change in Cash
-21
-19
26
-
53
-8
-16
-20
23

Nanobiotix Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-30
-50
-33
-47
-57
-39
-68
-23
Operating Cash Flow
-20
-25
-41
-27
-29
-37
-12
-19
-33
Investing Cash Flow
-1
0
-1
0
0
0
0
0
0
Financing Cash Flow
48
14
41
111
-5
-5
46
-5
37
Change in Cash
26
-11
-1
84
-35
-42
33
-25
3

Global Institutional Holdings in Nanobiotix

Funds
Holdings
BlackRock Inc
0%
Johnson & Johnson
11.09%
BNP Paribas Arbitrage, SA
0.01%
Marshall Wace Asset Management Ltd
0.02%
JPMorgan Chase & Co
0%
See all

Nanobiotix News & Key Events

  • img

    Today's Timeline - 30 March

    Mon, 12:00 PM

    -

    Nanobiotix presents promising Phase 2 trial data for JNJ-1900 in inoperable lung cancer, showing high efficacy and acceptable safety profile.

Insights on Nanobiotix

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NBTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NBTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 26.63M → 3.00M (in $), with an average decrease of 88.7% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -5.38M → -18.57M (in $), with an average decrease of 245.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NBTX stock has moved down by -26.8%

About Nanobiotix

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
OrganisationNanobiotix
Headquarters60 rue de Wattignies, Paris, France, 75012
IndustryBiotechnology
CEODr. Laurent Levy Ph.D.
E-voting on sharesClick here to vote

Key Management of Nanobiotix

Name

Title

Dr. Louis Kayitalire M.D.

Chief Medical Officer & Member of Executive Board

Mr. Brandon Owens

VP of Strategic Marketing & Corporate Communication

Dr. Leonard A. Farber M.D.

Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board

Mr. Bart Van Rhijn

Chief Financial & Business Officer and Member of Executive Board

Ms. Anne-Juliette Hermant M.A.

Chief People Officer & Member of Executive Board

Ms. Margaret Galluzzi

VP & Global Head of Clinical Operations

Ms. Anne-Sophie Lariviere

Chief Product Innovation & Delivery Officer

Dr. Laurent Levy Ph.D.

Co-Founder, President of the Executive Board & CEO

Mr. Earl J. Bergey Ph.d.

Co-Founder

FAQs

What is Nanobiotix share price today?

Nanobiotix share price today is $34.83 as on . Nanobiotix share today touched a day high of $35.99 and a low of $33.51.

What is the 52 week high and 52 week low for Nanobiotix share?

Nanobiotix share touched a 52 week high of $57.14 on and a 52 week low of $4.18 on . Nanobiotix stock price today i.e. is trending at $34.83,which is 39.04% down from its 52 week high and 733.25% up from its 52 week low.

What is Nanobiotix's market capitalisation today?

Nanobiotix market capitalisation is $0.00T as on .

How to invest in Nanobiotix Stock (NBTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nanobiotix on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nanobiotix Shares that will get you 0.0431 shares as per Nanobiotix share price of $34.83 per share as on June 13, 2026 at 1:05 am IST.

What is the minimum amount required to buy Nanobiotix Stock (NBTX) from India?

Indian investors can start investing in Nanobiotix (NBTX) shares with as little as ₹95.1 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.00 in Nanobiotix stock (as per the Rupee-Dollar exchange rate as on ). Based on Nanobiotix share’s latest price of $34.83 as on June 13, 2026 at 1:05 am IST, you will get 0.2871 shares of Nanobiotix. Learn more about fractional shares .